Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Nasopharyngitis, also known as common cold, is an infectious, inflammatory condition that affects the throat and nasal passages. The virus can spread through droplets in the air when someone who is sick coughs, sneezes, or talks. Symptoms include sore throat, runny nose, sneezing, fatigue, headache, and loss of appetite. Risk factors include age and weakened immune system. Treatment includes pain relievers and decongestant medications.
The nasopharyngitis (common cold) drugs in Development market report provides an overview of the Nasopharyngitis pipeline landscape. It provides comprehensive information on the therapeutics under development for Nasopharyngitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Nasopharyngitis and features dormant and discontinued projects.
What are the targets of the Nasopharyngitis pipeline drugs market?
The targets of the Nasopharyngitis pipeline drugs market are Alpha 1 Adrenergic Receptor, Glycylpeptide N Tetradecanoyltransferase, Histamine H1 Receptor, Mu Type Opioid Receptor, Prostaglandin G/H Synthase 1, and Prostaglandin G/H Synthase 2.
Nasopharyngitis pipeline drugs market, by targets
For more target insights, download a free report sample
What are the mechanisms of action of the Nasopharyngitis pipeline drugs market?
The mechanisms of action of the Nasopharyngitis pipeline drugs market are Alpha 1 Adrenergic Receptor Agonist, Glycylpeptide N Tetradecanoyltransferase Inhibitor, Histamine H1 Receptor Antagonist, Mu Type Opioid Receptor Agonist, Prostaglandin G/H Synthase 1 Inhibitor, and Prostaglandin G/H Synthase 2 Inhibitor.
Nasopharyngitis pipeline drugs market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
What are the routes of administration in the Nasopharyngitis pipeline drugs market?
The routes of administration in the Nasopharyngitis pipeline drugs market are oral and nasal.
Nasopharyngitis pipeline drugs market, by routes of administration
For more routes of administration insights, download a free report sample
What are the molecule types in the Nasopharyngitis pipeline drugs market?
The only molecule type in the Nasopharyngitis pipeline drugs market is small molecule.
Which are the key companies in the Nasopharyngitis pipeline drugs market?
Some of the key companies in the Nasopharyngitis pipeline drugs market are Adare Pharma Solutions, Charleston Laboratories Inc, Eurofarma Laboratorios SA, Firebrick Pharma Pty Ltd, Pfizer Inc, SaNOtize Research and Development Corp, SSP Co Ltd, and Tris Pharma Inc.
Nasopharyngitis pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report scope
Targets | Alpha 1 Adrenergic Receptor, Glycylpeptide N Tetradecanoyltransferase, Histamine H1 Receptor, Mu Type Opioid Receptor, Prostaglandin G/H Synthase 1, and Prostaglandin G/H Synthase 2 |
Mechanisms of Action | Alpha 1 Adrenergic Receptor Agonist, Glycylpeptide N Tetradecanoyltransferase Inhibitor, Histamine H1 Receptor Antagonist, Mu Type Opioid Receptor Agonist, Prostaglandin G/H Synthase 1 Inhibitor, and Prostaglandin G/H Synthase 2 Inhibitor |
Routes of Administration | Oral and Nasal |
Molecule Types | Small Molecule |
Key Companies | Adare Pharma Solutions, Charleston Laboratories Inc, Eurofarma Laboratorios SA, Firebrick Pharma Pty Ltd, Pfizer Inc, SaNOtize Research and Development Corp, SSP Co Ltd, and Tris Pharma Inc |
This report provides:
- A snapshot of the global therapeutic landscape of Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders).
- Reviews of pipeline therapeutics for Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Key companies involved in Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects.
- Evaluation of Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.
Charleston Laboratories Inc
Eurofarma Laboratorios SA
Firebrick Pharma Pty Ltd
Pfizer Inc
SaNOtize Research and Development Corp
SSP Co Ltd
Tris Pharma Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Nasopharyngitis pipeline drugs market?
The targets of the Nasopharyngitis pipeline drugs market are Alpha 1 Adrenergic Receptor, Glycylpeptide N Tetradecanoyltransferase, Histamine H1 Receptor, Mu Type Opioid Receptor, Prostaglandin G/H Synthase 1, and Prostaglandin G/H Synthase 2.
-
What are the mechanisms of action of the Nasopharyngitis pipeline drugs market?
The mechanisms of action of the Nasopharyngitis pipeline drugs market are Alpha 1 Adrenergic Receptor Agonist, Glycylpeptide N Tetradecanoyltransferase Inhibitor, Histamine H1 Receptor Antagonist, Mu Type Opioid Receptor Agonist, Prostaglandin G/H Synthase 1 Inhibitor, and Prostaglandin G/H Synthase 2 Inhibitor.
-
What are the routes of administration in the Nasopharyngitis pipeline drugs market?
The routes of administration in the Nasopharyngitis pipeline drugs market are oral and nasal.
-
What are the molecule types in the Nasopharyngitis pipeline drugs market?
The only molecule type in the Nasopharyngitis pipeline drugs market is small molecule.
-
Which are the key companies in the Nasopharyngitis pipeline drugs market?
Some of the key companies in the Nasopharyngitis pipeline drugs market are Adare Pharma Solutions, Charleston Laboratories Inc, Eurofarma Laboratorios SA, Firebrick Pharma Pty Ltd, Pfizer Inc, SaNOtize Research and Development Corp, SSP Co Ltd, and Tris Pharma Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.